- Home
- NDMO vs BVS Comparison
NDMO vs BVS Comparison
Compare NDMO & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NDMO | BVS |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 604.7M | 617.1M |
| IPO Year | 2019 | 2016 |
Fundamental Metrics
Financial Performance| Metric | NDMO | BVS |
|---|---|---|
| Price | $10.28 | $10.47 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 100.7K | ★ 403.4K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $7.52 |
| Revenue Next Year | N/A | $7.06 |
| P/E Ratio | ★ N/A | $30.65 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.57 | $5.81 |
| 52 Week High | $10.82 | $10.76 |
Technical Indicators
Market Signals| Indicator | NDMO | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 48.49 | 64.19 |
| Support Level | $10.25 | $8.43 |
| Resistance Level | $10.49 | $10.76 |
| Average True Range (ATR) | 0.11 | 0.41 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 36.96 | 77.06 |
Price Performance
Historical ComparisonAbout NDMO Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest
Nuveen Dynamic Municipal Opportunities is a closed-end management investment company. Its investment objective is to seek total return through income exempt from regular federal income taxes and capital appreciation. A majority of its investments are made in municipal securities, the income from which is exempted from regular federal income taxes.
About BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.